Page last updated: 2024-08-16

ribavirin and Asymptomatic Colonization

ribavirin has been researched along with Asymptomatic Colonization in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engström, L; Lewensohn-Fuchs, I; Ljungman, P; Omar, H; Orvell, C; Pérez-Bercoff, L; Vuong, GK; Yun, Z1
Galoppo, C; Galoppo, M1
Alekseeva, LA; Bessonova, TV; Goriacheva, LG; Kotiv, MIa; Romantsov, MG; Vasil'eva, DK1

Other Studies

3 other study(ies) available for ribavirin and Asymptomatic Colonization

ArticleYear
Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:5

    Topics: Adenoviridae Infections; Adult; Antiviral Agents; Asymptomatic Infections; Child; Child, Preschool; Cidofovir; Cohort Studies; Cytosine; DNA, Viral; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load; Viremia; Young Adult

2010
Management of hepatitis C virus infection in childhood.
    Annals of hepatology, 2010, Volume: 9 Suppl

    Topics: Antiviral Agents; Asymptomatic Infections; Biopsy; Child; Child, Preschool; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C Antibodies; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon-alpha; Ribavirin; Risk Factors; RNA, Viral; Treatment Outcome; Viral Load

2010
[Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4

    Topics: Acridines; Adolescent; Antiviral Agents; Asymptomatic Infections; Biomarkers; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon Inducers; Interferon-alpha; Ribavirin; Treatment Outcome

2011